Global Mesalazine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Mesalazine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn"s disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

According to our (Global Info Research) latest study, the global Mesalazine market size was valued at US$ 185 million in 2023 and is forecast to a readjusted size of USD 236 million by 2030 with a CAGR of 3.6% during review period.

Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

This report is a detailed and comprehensive analysis for global Mesalazine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Mesalazine market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030

Global Mesalazine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030

Global Mesalazine market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2019-2030

Global Mesalazine market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Mesalazine

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Mesalazine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Mesalazine market is split by Purity and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Purity
Above 97 %
Above 98 %
Above 99 %

Market segment by Application
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others

Major players covered
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Mesalazine product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Mesalazine, with price, sales quantity, revenue, and global market share of Mesalazine from 2019 to 2024.

Chapter 3, the Mesalazine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Mesalazine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Purity and by Application, with sales market share and growth rate by Purity, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Mesalazine market forecast, by regions, by Purity, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Mesalazine.

Chapter 14 and 15, to describe Mesalazine sales channel, distributors, customers, research findings and conclusion.